Nan Wang, Feng Ke, Jing Li, Tingting Ren, Rui Liu, Fuxiao Luan, Liangyuan Xu, Jianmin Ma
{"title":"单侧视网膜母细胞瘤术后眼眶发育的长期观察","authors":"Nan Wang, Feng Ke, Jing Li, Tingting Ren, Rui Liu, Fuxiao Luan, Liangyuan Xu, Jianmin Ma","doi":"10.1002/cam4.71282","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>This study aims to investigate bilateral orbital development differences and influencing factors in retinoblastoma patients undergoing unilateral enucleation.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A retrospective comparative analysis was performed on patients from Beijing Tongren Hospital (January 2011–December 2020). Preoperative and 3 months, 1 year, 3 years postoperative, and the final follow-up imaging data were collected, with bilateral orbital volumes reconstructed using ITK-SNAP software.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Thirty-nine patients were followed for an average of 7.7 ± 2.45 years. Average orbital volumes (mm<sup>3</sup>) for the surgical and nonsurgical sides before surgery were 14,323.81 ± 4596.60 and 14,457.93 ± 4732.26 (<i>p</i> = 0.330). Postoperative volumes at 3 months were 16,481.84 ± 4034.21 and 16,866.45 ± 3999.71 (<i>p</i> = 0.007). At 12 months, volumes were 16,798.16 ± 3323.33 and 18,119.16 ± 3840.27 (<i>p</i> = 0.000). At 36 months, volumes were 18,758.26 ± 2917.35 and 19,973.55 ± 3189.83 (<i>p</i> = 0.000). The last follow-up volumes were 20,523.78 ± 3221.20 and 21,576.78 ± 3381.96 (<i>p</i> = 0.000). Bilateral volume differences were 2.28%, 7.29%, 6.08%, and 4.88% at 3 months, 12 months, 36 months after operation, and final follow-up. The growth trajectory on the surgical side demonstrated growth restrictions, accompanied by a shift in the growth peak. Factors affecting development included the age at the time of operation and the type of orbital implants.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Volumetric analysis revealed active orbital development between 3 and 12 months post-enucleation, followed by a significant plateau phase. The final orbital volume deficit in the surgical orbit stabilized at approximately 5% compared to the non-operated orbit. Hydrogel implants demonstrated a trade-off: potentially reduced volume deficit but higher complication risks.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 19","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71282","citationCount":"0","resultStr":"{\"title\":\"Long-Term Observation of Orbital Development in Patients With Retinoblastoma Following Unilateral Enucleation\",\"authors\":\"Nan Wang, Feng Ke, Jing Li, Tingting Ren, Rui Liu, Fuxiao Luan, Liangyuan Xu, Jianmin Ma\",\"doi\":\"10.1002/cam4.71282\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>This study aims to investigate bilateral orbital development differences and influencing factors in retinoblastoma patients undergoing unilateral enucleation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A retrospective comparative analysis was performed on patients from Beijing Tongren Hospital (January 2011–December 2020). Preoperative and 3 months, 1 year, 3 years postoperative, and the final follow-up imaging data were collected, with bilateral orbital volumes reconstructed using ITK-SNAP software.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Thirty-nine patients were followed for an average of 7.7 ± 2.45 years. Average orbital volumes (mm<sup>3</sup>) for the surgical and nonsurgical sides before surgery were 14,323.81 ± 4596.60 and 14,457.93 ± 4732.26 (<i>p</i> = 0.330). Postoperative volumes at 3 months were 16,481.84 ± 4034.21 and 16,866.45 ± 3999.71 (<i>p</i> = 0.007). At 12 months, volumes were 16,798.16 ± 3323.33 and 18,119.16 ± 3840.27 (<i>p</i> = 0.000). At 36 months, volumes were 18,758.26 ± 2917.35 and 19,973.55 ± 3189.83 (<i>p</i> = 0.000). The last follow-up volumes were 20,523.78 ± 3221.20 and 21,576.78 ± 3381.96 (<i>p</i> = 0.000). Bilateral volume differences were 2.28%, 7.29%, 6.08%, and 4.88% at 3 months, 12 months, 36 months after operation, and final follow-up. The growth trajectory on the surgical side demonstrated growth restrictions, accompanied by a shift in the growth peak. Factors affecting development included the age at the time of operation and the type of orbital implants.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Volumetric analysis revealed active orbital development between 3 and 12 months post-enucleation, followed by a significant plateau phase. The final orbital volume deficit in the surgical orbit stabilized at approximately 5% compared to the non-operated orbit. Hydrogel implants demonstrated a trade-off: potentially reduced volume deficit but higher complication risks.</p>\\n </section>\\n </div>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 19\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71282\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71282\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71282","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Long-Term Observation of Orbital Development in Patients With Retinoblastoma Following Unilateral Enucleation
Background
This study aims to investigate bilateral orbital development differences and influencing factors in retinoblastoma patients undergoing unilateral enucleation.
Methods
A retrospective comparative analysis was performed on patients from Beijing Tongren Hospital (January 2011–December 2020). Preoperative and 3 months, 1 year, 3 years postoperative, and the final follow-up imaging data were collected, with bilateral orbital volumes reconstructed using ITK-SNAP software.
Results
Thirty-nine patients were followed for an average of 7.7 ± 2.45 years. Average orbital volumes (mm3) for the surgical and nonsurgical sides before surgery were 14,323.81 ± 4596.60 and 14,457.93 ± 4732.26 (p = 0.330). Postoperative volumes at 3 months were 16,481.84 ± 4034.21 and 16,866.45 ± 3999.71 (p = 0.007). At 12 months, volumes were 16,798.16 ± 3323.33 and 18,119.16 ± 3840.27 (p = 0.000). At 36 months, volumes were 18,758.26 ± 2917.35 and 19,973.55 ± 3189.83 (p = 0.000). The last follow-up volumes were 20,523.78 ± 3221.20 and 21,576.78 ± 3381.96 (p = 0.000). Bilateral volume differences were 2.28%, 7.29%, 6.08%, and 4.88% at 3 months, 12 months, 36 months after operation, and final follow-up. The growth trajectory on the surgical side demonstrated growth restrictions, accompanied by a shift in the growth peak. Factors affecting development included the age at the time of operation and the type of orbital implants.
Conclusions
Volumetric analysis revealed active orbital development between 3 and 12 months post-enucleation, followed by a significant plateau phase. The final orbital volume deficit in the surgical orbit stabilized at approximately 5% compared to the non-operated orbit. Hydrogel implants demonstrated a trade-off: potentially reduced volume deficit but higher complication risks.
期刊介绍:
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.